Exercise of Options - Issue of Equity
Source: RNS
3 July 2024
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group")
Exercise of Options - Issue of Equity
CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE") announces that today 1,500,000 new Ordinary Shares (the 'New Ordinary Shares') were issued pursuant to the exercise of options under the Company's Unapproved Share Option Scheme.
Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). Dealings in the New Ordinary Shares are expected to commence on or around 8.00 a.m. on 8 July 2024.
Following Admission, the Company's enlarged issued share capital will comprise 269,684,127 ordinary shares with voting rights in the Company. As the Company holds no shares in treasury, this is the total number of the voting rights in the Company which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change in the interest, in the share capital of the Company under Chapter 5 of the FCA's Disclosure Guidance and Transparency Rules as reflected in the Company's articles of incorporation.
ENDS
For more information, please contact:
Clean Power Hydrogen plc |
via Camarco |
Jon Duffy, Chief Executive Officer |
|
James Hobson, Chief Financial Officer |
|
|
|
Cavendish Capital Markets Limited - NOMAD & Broker |
|
Neil McDonald |
+44 (0)131 220 9771 |
Peter Lynch |
+44 (0)131 220 9772 |
Adam Rae |
+44 (0)131 220 9778 |
|
|
Camarco PR |
+ 44(0) 20 3757 4980 |
Billy Clegg |
|
Owen Roberts |
|
Lily Pettifar |
|
To find out more, please visit: https://www.cph2.com
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.